EUVIMEDOpdag EUVIMED
Crossref

ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES

Abhishek Sharma, Deepali Sharma, Ayush Gupta

EPRA International Journal of Research & Development (IJRD) · 2026-03-20 · 310

DOI: 10.36713/epra26594 ↗

At a glance

Journal article in EPRA International Journal of Research & Development (IJRD), published online on 2026-03-20. Written by Abhishek Sharma and 2 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Adverse Drug Reactions (ADRs) are a major concern in clinical practice and significantly contribute to morbidity and mortality worldwide [1]. Pharmacovigilance plays a crucial role in detecting, assessing, and preventing ADRs [2]. In India, the Pharmacovigilance Programme of India (PvPI) has been established to monitor drug safety [3]. However, underreporting remains a major challenge due to lack of awareness and inadequate training [4].

Cite

APA

Sharma, A., Sharma, D., & Gupta, A. (2026). ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES. EPRA International Journal of Research & Development (IJRD), 310. https://doi.org/10.36713/epra26594

Vancouver

Sharma A, Sharma D, Gupta A. ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES. EPRA International Journal of Research & Development (IJRD). 2026:310. doi:10.36713/epra26594

BibTeX
@article{Sharma2026,
  author = {Sharma, Abhishek and Sharma, Deepali and Gupta, Ayush},
  title = {ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES},
  journal = {EPRA International Journal of Research & Development (IJRD)},
  year = {2026},
  pages = {310},
  doi = {10.36713/epra26594}
}
Start for free →